Related Experiment Videos
Sudden death in ischemic heart disease - 2017
1Harvard Medical School, Boston, MA, USA; Clinical Electrophysiology and ECG Laboratories, Beth Israel Deaconess Medical Center, Boston, MA, USA.
International Journal of Cardiology
|April 3, 2017
Summary
Current implantable cardioverter-defibrillator (ICD) guidelines for coronary heart disease (CHD) patients miss many who could benefit and expose others to risks. New models using clinical markers can improve ICD use for sudden cardiac death (SCD) prevention.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Technology
Background:
- Current guidelines for implantable cardioverter-defibrillators (ICDs) in coronary heart disease (CHD) patients are primarily based on broad mortality risk reduction from randomized trials.
- These trials often overlook the specific pathophysiology of ventricular tachyarrhythmias and sudden cardiac death (SCD) in CHD.
- This approach leads to suboptimal ICD utilization, missing eligible patients and exposing others to unnecessary risks and costs.
Purpose of the Study:
- To explore strategies for advancing the use of ICDs in CHD patients to improve survival.
- To identify methods for more precise patient selection for ICD therapy.
- To better understand and address the mechanisms of SCD in CHD.
Main Methods:
- Review of existing guidelines and randomized clinical trial methodologies for ICD use in CHD.
- Discussion of predictive models utilizing comorbidities and clinical markers to identify patients unlikely to benefit from ICDs.
- Exploration of the role of autonomic nervous system, hemodynamic conditions, and left ventricular geometry in arrhythmogenesis.
- Consideration of animal models and human physiological studies for post-infarction arrhythmias.
Main Results:
- Existing guidelines may not accurately identify all patients who would benefit from ICDs, nor exclude those who would not.
- Predictive models using comorbidities show potential for improving ICD appropriateness.
- Multiple mechanisms, influenced by autonomic and hemodynamic factors, contribute to SCD in CHD.
- Altered left ventricular geometry and autonomic interactions play roles in arrhythmia genesis.
Conclusions:
- There is a need to refine ICD selection criteria beyond broad mortality risk, potentially using predictive models based on clinical markers.
- Further research into the complex mechanisms of SCD in CHD, including autonomic and hemodynamic influences, is crucial.
- Prospective validation of predictive models and integration of basic science findings into clinical trials are necessary to optimize ICD therapy and reduce SCD in CHD patients.